Avista Therapeutics Signs Gene Therapy Partnership with Roche for US$1 B

By Neha Madhwani

Pharma Deals Review: Vol 2022 Issue 8 (Table of Contents)

Published: 4 Aug-2022

DOI: 10.3833/pdr.v2022.i8.2712     ISSN: 1756-7874

Section: Licensing



Avista Therapeutics has partnered with Roche to develop adeno-associated virus (AAV) gene therapy vectors for eye diseases...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details